Article Text
Statistics from Altmetric.com
Footnotes
Handling editor Josef S Smolen
Collaborators Great Paris Region (GPR) Kawa-COVID-19 consortium: Charlotte Borocco, MD(Department of Pediatric Rheumatology, Hôpital Bicêtre, AP-HP, Reference centre for Autoinflammatory diseases and amyloidosis (CEREMAIA), Le Kremlin-Bicêtre, France, Department of Immunology, Robert Debré University Hospital, AP-HP, Paris, France), Marion Caseris MD (General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré University Hospital, AP-HP, Paris, France, Reference centre for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Paris, France, Department of Microbiology, Robert Debré University Hospital, AP-HP, Paris, France), Johanna Lokmer MD (Cardiopaediatric Unit, Robert Debré University Hospital, AP-HP, Paris, France), Cherine Benzouid MD (Cardiopaediatric Unit, Robert Debré University Hospital, AP-HP, Paris, France), Constance Beyler MD (Cardiopaediatric Unit, Robert Debré University Hospital, AP-HP, Paris, France), Romain Basmaci MD, PhD (Departments of General Paediatrics and Paediatric Emergency, Louis-Mourier Hospital, AP-HP, Colombes, France, Infection-Antimicrobials-Modelling-Evolution IAME, INSERM, UMR-1137, Université de Paris, 75018, Paris, France), Noémie Lachaume MD (Departments of General Paediatrics and Paediatric Emergency, Louis-Mourier Hospital, AP-HP, Colombes, France, Infection-Antimicrobials-Modelling-Evolution IAME, INSERM, UMR-1137, Université de Paris, 75018, Paris, France), Philippe Bensaid MD (Department of General Paediatrics, Victor Dupouy Hospital, Argenteuil, France), Samia Pichard MD (Department of General Paediatrics, Victor Dupouy Hospital, Argenteuil, France), Hanane Kouider MD (Department of General Paediatrics, René Dubos, Pontoise Hospital, France), Guillaume Morelle MD (Department of General Paediatrics Hôpital Bicêtre, AP-HP, Kremlin-Bicêtre, France), Irina Craiu MD (Paediatric emergency Department, Hôpital Bicêtre, AP-HP, Kremlin-Bicêtre, France), Corinne Pondarre MD, PhD (Sickle cell disease referal center, Centre hospitalier Intercommunal de Créteil, INSERM U955, Paris XII University), Arielle Maroni MD (Université de Paris, UFR de Médecine Paris Nord, 75010 Paris, France, Paediatric Intensive Care Unit, Robert Debré University Hospital, AP-HP, Paris, France), Anna Deho, MD (Paediatric Intensive Care Unit, Robert Debré University Hospital, AP-HP, Paris, France), Mehdi Oualha MD, PhD (Paediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, AP-HP, Paris, France), Zahir Amoura MD, MSc (Sorbonne Université, Inserm UMR-S 1135, Department of Immunology and Infectious disease (CIMI-Paris), Pitié-Salpêtrière Hospital, AP-HP, Paris, France), Julien Haroche MD, PhD (Sorbonne Université, Inserm UMR-S 1135, Department of Immunology and Infectious disease (CIMI-Paris), Pitié-Salpêtrière Hospital, AP-HP, Paris, France), Juliette Chommeloux MD (Medical Intensive Care Unit, Institut de Cardiologie, AP-HP, Sorbonne University, Pitié-Salpêtrière Hospital, Paris, France), Fanny Bajolle MD, PhD (Cardiopaediatric Unit, M3-C Necker-Enfants-Malades University Hospital, AP-HP, Paris, France), Stéphane Bonacorsi MD, PhD (Université de Paris, UFR de Médecine Paris Nord, 75010 Paris, France, Department of Microbiology, Robert Debré University Hospital, AP-HP, Paris, France, Infection-Antimicrobials-Modelling-Evolution IAME, INSERM, UMR-1137, Université de Paris, 75018, Paris, France), Guislaine Carcelain MD, PhD (Department of Immunology, Robert Debré University Hospital, AP-HP, Paris, France), Isabelle Kone-Paut MD (Department of Pediatric Rheumatology, Hôpital Bicêtre, AP-HP, Reference centre for Autoinflammatory diseases and amyloidosis (CEREMAIA), Le Kremlin-Bicêtre, France, Department of Immunology, Robert Debré University Hospital, AP-HP, Paris, France), Brigitte Bader-Meunier MD (Paediatric Hematology-Immunology and Rheumatology Department, Necker-Enfants-Malades University Hospital, AP-HP, Paris, France, Reference centre for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Paris, France, Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Paris, France).
Contributors MP, GD, NO, AF, CG and IM designed the study. MP, GD, NO, OC, CD, UM, AF, CG and IM collected clinical data. MP, CG and IM wrote the paper. CG, AF, and IM supervised the study. All authors have read final approval of the version published.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting or dissemination plans of this research.
Provenance and peer review Commissioned; internally peer reviewed.